Literature DB >> 25156065

Attentional bias and metacognitions in cancer survivors with high fear of cancer recurrence.

P Butow1, S Kelly, B Thewes, G Hruby, L Sharpe, J Beith.   

Abstract

BACKGROUND: Fear of cancer recurrence (FCR) is a common and severe problem amongst cancer survivors, but mechanisms to explain its development and maintenance are still lacking. The self-regulatory executive function (S-REF) model suggests that metacognitions and attentional bias to cancer-related words may explain high FCR. Thus, this study aimed to explore relationships between FCR, metacognitions and attentional bias in a mixed group of cancer survivors.
METHOD: Sixty-three early-stage breast or prostate cancer survivors, diagnosed within 6 months to 5 years prior to participation and who had completed all hospital-based treatment with no evidence of cancer recurrence were recruited through two metropolitan oncology clinics. Participants completed a questionnaire battery and the dot-probe task.
RESULTS: Survivors with clinical FCR had significantly greater positive beliefs about worry (10.1 vs 7.4, p = 0.002) and beliefs about the uncontrollability and danger of worry (12.0 vs 7.7, p = 0.000) than those with non-clinical FCR, whereas the total metacognition score significantly predicted FCR in multiple regression analysis (β = 0.371, p = 0.001). No significant differences were detected between participants scoring above and below clinical FCR levels in attention bias indices.
CONCLUSIONS: This study found partial support for the S-REF model of FCR, with metacognitions but not attentional bias found to be related to FCR. Further research is needed to explore attentional biases in more detail.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  attentional bias; cancer; fear of recurrence

Mesh:

Year:  2014        PMID: 25156065     DOI: 10.1002/pon.3659

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  20 in total

Review 1.  Fear of cancer recurrence: a theoretical review and novel cognitive processing formulation.

Authors:  Joanna E Fardell; Belinda Thewes; Jane Turner; Jemma Gilchrist; Louise Sharpe; Allan 'Ben' Smith; Afaf Girgis; Phyllis Butow
Journal:  J Cancer Surviv       Date:  2016-01-19       Impact factor: 4.442

2.  A pilot randomised controlled trial of an online mindfulness-based program for people diagnosed with melanoma.

Authors:  Lahiru Russell; Anna Ugalde; Liliana Orellana; Donna Milne; Meinir Krishnasamy; Richard Chambers; David W Austin; Patricia M Livingston
Journal:  Support Care Cancer       Date:  2018-11-30       Impact factor: 3.603

3.  Medical, demographic and psychological correlates of fear of cancer recurrence (FCR) morbidity in breast, colorectal and melanoma cancer survivors with probable clinically significant FCR seeking psychological treatment through the ConquerFear study.

Authors:  Allan 'Ben' Smith; Louise Sharpe; Belinda Thewes; Jane Turner; Jemma Gilchrist; Joanna E Fardell; Afaf Girgis; Stephanie Tesson; Joseph Descallar; Melanie L Bell; Jane Beith; Phyllis Butow
Journal:  Support Care Cancer       Date:  2018-06-07       Impact factor: 3.603

4.  Fear of Cancer Recurrence: A Model Examination of Physical Symptoms, Emotional Distress, and Health Behavior Change.

Authors:  Daniel L Hall; Rachel B Jimenez; Giselle K Perez; Julia Rabin; Katharine Quain; Gloria Y Yeh; Elyse R Park; Jeffrey M Peppercorn
Journal:  J Oncol Pract       Date:  2019-07-12       Impact factor: 3.840

5.  Reproduction-related cognitive processing and distress among young adult women: the role of personal breast cancer history.

Authors:  Ana Bártolo; Isabel M Santos; Raquel Guimarães; Salomé Reis; Sara Monteiro
Journal:  Cogn Process       Date:  2021-04-02

6.  Testing a model of fear of cancer recurrence or progression: the central role of intrusions, death anxiety and threat appraisal.

Authors:  L Curran; L Sharpe; C MacCann; P Butow
Journal:  J Behav Med       Date:  2020-01-06

7.  Mind-body interventions for fear of cancer recurrence: A systematic review and meta-analysis.

Authors:  Daniel L Hall; Christina M Luberto; Lisa L Philpotts; Rhayun Song; Elyse R Park; Gloria Y Yeh
Journal:  Psychooncology       Date:  2018-06-05       Impact factor: 3.894

8.  Anxiety, fatigue, and attentional bias toward threat in patients with hematopoietic tumors.

Authors:  Kohei Koizumi; Jun Tayama; Toshiyuki Ishioka; Hiromi Nakamura-Thomas; Makoto Suzuki; Motohiko Hara; Shigeru Makita; Toyohiro Hamaguchi
Journal:  PLoS One       Date:  2018-02-05       Impact factor: 3.240

9.  Feasibility of an online mindfulness-based program for patients with melanoma: study protocol for a randomised controlled trial.

Authors:  Lahiru Russell; Anna Ugalde; Donna Milne; Meinir Krishnasamy; Eric O Seung Chul; David W Austin; Richard Chambers; Liliana Orellana; Patricia M Livingston
Journal:  Trials       Date:  2018-04-13       Impact factor: 2.279

10.  Metacognitive Therapy for Emotional Distress in Adult Cancer Survivors: A Case Series.

Authors:  Peter L Fisher; Angela Byrne; Peter Salmon
Journal:  Cognit Ther Res       Date:  2017-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.